Do vaccines cause epilepsy? Review of cases in the National Vaccine Injury Compensation Program.
Level 4 - case-series / case-control
Retrospective case series / review of legal adjudications
PubMed 37914395 · doi:10.1111/epi.17794
What was done
The authors conducted a retrospective review of publicly available legal cases involving epilepsy claims within the US National Vaccine Injury Compensation Program (VICP), searched through Westlaw and US Court of Federal Claims databases. They evaluated petitioners' causation theories, respondents' counterarguments, final court rulings, and the rationale underlying compensation decisions.
What was found
The authors identified 532 unique cases of epilepsy in the VICP: 105 involving infantile spasms and 427 involving epilepsy without infantile spasms. The analysis noted key historical shifts, including the removal of residual seizure disorder as a compensable injury, adoption of the Althen prongs, introduction of acellular pertussis vaccines, and recognition of underlying genetic etiologies. Petitioners' experts frequently espoused causation theories that lacked acceptable scientific foundations and were criticized by the court. No specific compensation rates or numerical outcome proportions were reported in the abstract.
Why it matters
This review highlights the divergence between scientific understanding and legal arguments presented in vaccine litigation, suggesting that legal standards for compensating epilepsy claims require reconsideration.
Limits
The study is a review of legal decisions rather than a controlled epidemiological study, so it cannot assess true incidence, causation, or clinical risk. Findings reflect only publicly available US VICP court records and petitioner arguments.
Cited by
- supports The US federal government has paid out over 5 billion dollars through the National Vaccine Injury Compensation Program for vaccine injuries.